Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yichen Sun

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
NPJ Parkinson'S Disease|November 18, 2024
Circulating blood circular RNA in Parkinson's Disease; from involvement in pathology to diagnostic tools in at-risk individualsAleksandra Beric, Yichen Sun, Santiago Sanchez, et al.
Cell Death & Disease|August 10, 2023
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinomaLizhen Liu, Peng Deng, Sailan Liu, et al.
Nano Letters|July 1, 2021
Pressure-Tuned Intralayer Exchange in Superlattice-Like MnBi<sub>2</sub>Te<sub>4</sub>/(Bi<sub>2</sub>Te<sub>3</sub>)<i></i> Topological InsulatorsJifeng Shao, Yuntian Liu, Meng Zeng, et al.
Cancer Research|January 6, 2021
Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal CarcinomaLizhen Liu, Sailan Liu, Peng Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 16, 2024
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian CancerShini Liu, Peng Deng, Zhaoliang Yu, et al.
Molecular Cancer|May 20, 2023
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancerJianfeng Chen, Jing Han Hong, Yulin Huang, et al.
Medcomm|June 19, 2023
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphomaYali Wang, Wenbo Zhou, Jianfeng Chen, et al.
JCI Insight|June 6, 2024
4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancerJiaxin Yin, Jianfeng Chen, Jing Han Hong, et al.
Oncogene|May 23, 2024
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expressionYichen Sun, Jianfeng Chen, Jing Han Hong, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
NPJ Parkinson'S Disease|November 18, 2024
Circulating blood circular RNA in Parkinson's Disease; from involvement in pathology to diagnostic tools in at-risk individualsAleksandra Beric, Yichen Sun, Santiago Sanchez, et al.
Cell Death & Disease|August 10, 2023
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinomaLizhen Liu, Peng Deng, Sailan Liu, et al.
Nano Letters|July 1, 2021
Pressure-Tuned Intralayer Exchange in Superlattice-Like MnBi<sub>2</sub>Te<sub>4</sub>/(Bi<sub>2</sub>Te<sub>3</sub>)<i></i> Topological InsulatorsJifeng Shao, Yuntian Liu, Meng Zeng, et al.
Cancer Research|January 6, 2021
Targeting the IRAK1-S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal CarcinomaLizhen Liu, Sailan Liu, Peng Deng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 16, 2024
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian CancerShini Liu, Peng Deng, Zhaoliang Yu, et al.
Molecular Cancer|May 20, 2023
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancerJianfeng Chen, Jing Han Hong, Yulin Huang, et al.
Medcomm|June 19, 2023
Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphomaYali Wang, Wenbo Zhou, Jianfeng Chen, et al.
JCI Insight|June 6, 2024
4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancerJiaxin Yin, Jianfeng Chen, Jing Han Hong, et al.
Oncogene|May 23, 2024
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expressionYichen Sun, Jianfeng Chen, Jing Han Hong, et al.
NPJ Parkinson'S Disease|July 8, 2023
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's diseaseBridget Phillips, Daniel Western, Lihua Wang, et al.
Pageof 7